Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01611285 · ClinicalTrials.gov registry record
Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach
A clinical trial, sponsored by Atlantic Health System.
- Completed
- Registry status
- 20
- Enrollment target
NCT01611285: Completed study, sponsored by Atlantic Health System.
NCT01611285 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01611285 has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Within the general objective of investigating optimal medical techniques for pelvic prolapse repair, this study proposes to: (1) test the hypothesis that the UPHOLD procedure is more cost effective than robotic surgery for pelvic prolapse repair (2)using formal decision analysis as the comparative strategy
Primary Outcome
Incidence of recurrance of pelvic organ prolapse within 12 months of either robotic sacrocolpopexy or the UPHOLD procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-08 |
What the finished NCT01611285 record still lists
NCT01611285 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01611285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01611285 about?
NCT01611285 is a clinical study titled "Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach". Within the general objective of investigating optimal medical techniques for pelvic prolapse repair, this study proposes to: (1) test the hypothesis that the UPHOLD procedure is more cost effective than robotic surgery for pelvic prolapse repair (2)using formal decision analysis as the comparative s...
What is the current status of trial NCT01611285?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-11. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01611285?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia